These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10960185)

  • 1. Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.
    Diouf O; Depreux P; Chavatte P; Poupaert JH
    Eur J Med Chem; 2000; 35(7-8):699-706. PubMed ID: 10960185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites.
    Langlois M; Brémont B; Shen S; Poncet A; Andrieux J; Sicsic S; Serraz I; Mathé-Allainmat M; Renard P; Delagrange P
    J Med Chem; 1995 Jun; 38(12):2050-60. PubMed ID: 7783136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands.
    Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T
    Eur J Med Chem; 2000 Dec; 35(12):1065-79. PubMed ID: 11248405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
    López-Rodríguez ML; Porras E; Morcillo MJ; Benhamú B; Soto LJ; Lavandera JL; Ramos JA; Olivella M; Campillo M; Pardo L
    J Med Chem; 2003 Dec; 46(26):5638-50. PubMed ID: 14667218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
    López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
    Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
    Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO
    Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
    López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
    J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro binding studies of piperazine-alkyl-naphthamides: impact of homology and sulphonamide/carboxamide bioisosteric replacement on the affinity for 5-HT1A, alpha2A, D4.2, D3 and D2L receptors.
    Résimont M; Liégeois JF
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5199-202. PubMed ID: 20656482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.
    van Wijngaarden I; Hamminga D; van Hes R; Standaar PJ; Tipker J; Tulp MT; Mol F; Olivier B; de Jonge A
    J Med Chem; 1993 Nov; 36(23):3693-9. PubMed ID: 8246239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
    Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
    Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
    Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
    J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
    Kim HJ; Yun HM; Kim T; Nam G; Roh EJ; Kostenis E; Choo HY; Pae AN; Rhim H
    Comb Chem High Throughput Screen; 2008 May; 11(4):316-24. PubMed ID: 18473741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
    Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M
    Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP; Kung MP; Mu M; Kung HF
    J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.